Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Charmaine Gittleson bought 1,666,666 shares of the stock in a transaction on Tuesday, December 31st. The stock was bought at an average price of A$0.01 ($0.01) per share, for a total transaction of A$14,999.99 ($9,316.77).
Percheron Therapeutics Price Performance
Percheron Therapeutics Company Profile
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Featured Stories
- Five stocks we like better than Percheron Therapeutics
- Investing in Commodities: What Are They? How to Invest in Them
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- How to Use the MarketBeat Excel Dividend Calculator
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
